The head-twitch response in rodents indicates stimulation of the 5-HT2A receptor. This knowledge helps researchers design experiments to understand how psychedelics work.
This is the first time researchers have correlated psilocin bound to 5-HT2A receptors in the brain, levels of psilocin in the blood, and subjective experiences.
Magic mushrooms may be synthesizing this newly-discovered compound from baeocystin.
Psilocybin produces more insightful and mystical experiences, but dextromethorphan causes greater feelings of disembodiment.
Data analysis and gene expression maps confirm the role of the 5-HT2A receptor in the effects of LSD.
Psilocin makes neurons grow faster and produce more connections.
A study in the mouse brain shows serotonin neurons are organized into parallel subsystems.
The metabolism of psilocybin (and psilocin) is frequently cited. But, the supporting references are seldom discussed.
Psilocybin has been rapidly gaining traction as a safe, fast-acting, and effective treatment for many mood disorders such as anxiety and depression. Now, psilocybin is showing promise for neuroregeneration and motor recovery in methods of treating phantom pain.
Researchers measured the effects of psilocybin by comparing brain scans.